Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.115 USD | -2.53% | +0.70% | -69.00% |
Apr. 29 | Immix Biopharma Gets Orphan Drug Label in Europe For Multiple Myeloma Treatment | MT |
Apr. 18 | Immix Biopharma on Track to Dose First Patients with AL Amyloidosis Therapy by Mid-Year | MT |
- Stock Market
- Equities
- IMMX Stock
- News Immix Biopharma, Inc.
- Trading Ideas